Prospects for xenotransplantation

Current Opinion in Immunology

Volumn 12, Issue 5, 2000, Pages 563-568

  Logan, John S ^a  

^a Nextran   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD59 ANTIGEN; COMPLEMENT; COMPLEMENT MEMBRANE ATTACK COMPLEX; DECAY ACCELERATING FACTOR; GLYCOSYLTRANSFERASE; MEMBRANE COFACTOR PROTEIN; REGULATOR PROTEIN;

GENE; GRAFT REJECTION; IMMUNE RESPONSE; IMMUNOPATHOLOGY; NONHUMAN; REVIEW; XENOTRANSPLANTATION;

EID: 0033817426     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(00)00139-4     Document Type: Review

References (69)

1. The potential supply of organ donors: An assessment of the efficiency of organ procurement efforts in the United States
2. Effects of cyclosporine and antibody adsorption on pig cardiac xenograft survival in the baboon
3. Immunopathology of hyperacute xenograft rejection in a swine-to-primate model
4. Inhibition of anti-gal IgG binding to porcine endothelial cells by synthetic oligosaccharides
5. Identification of carbohydrate structures which bind human anti-porcine antibodies: Implications for discordant grafting in man
6. Enzymatic removal of alpha-galactosyl epitopes from porcine endothelial cells diminishes the cytotoxic effect of natural antibodies
7. The role of natural anti-Galα1-3Gal antibodies in hyperacute rejection of pig-to-baboon cardiac xenotransplants
8. Protection of pig kidney (PK15) cells from the cytotoxic effect of anti-pig antibodies by α-galactosyl oligosaccharides
9. Anti-pig IgM antibodies in human serum react predominantly with Galα(1,3)Gal epitopes
10. In vivo immunoadsorption of antipig antibodies in baboons using a specific Galα1-3Gal column
11. Removal of terminal α-galactosyl residues from xenogeneic porcine endothelial cells
12. Characterization of porcine endothelial cell determinants recognized by human natural antibodies
13. Evolutionary relationship between the natural anti-Gal antibody and the Galα1→3Gal epitope in primates
14. Man, apes and old world monkeys differ from other mammals in the expression of α-galactosyl epitopes on nucleated cells
15. Interaction between human natural anti-alpha-galactosyl immunoglobulin G and bacteria of the human flora
16. Delayed xenograft rejection of pig-to-baboon cardiac transplants after cobra venom factor therapy
17. Effect of continuous complement inhibition using soluble complement receptor type 1 survival of pig-to-primate cardiac xenografts
18. Separation of self from non-self in the complement system
19. The mechanism of discordant xenograft rejection
20. Transplantation of discordant xenografts: A review of progress
21. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury
22. Life supporting pig-to-primate renal xenotransplantation using genetically modified donors
23. Orthotopic heart transplantation in a transgenic pig-to-primate model
24. Life-supporting pig-to-baboon heart xenotransplantation
25. Potential use of genetically modified pigs as organ donors for transplantation into humans
26. Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage
27. Characterization in vitro and in vivo of the pig analogue of human CD59 using new monoclonal antibodies
28. Distribution of membrane cofactor protein (MCP/CD46) on pig tissues. Relevance to xenotransplantation
29. Complement-inhibiting activities of human CD59 and analogues from rat, sheep, and pig are not homologously restricted
30. Purification and characterization of the pig analogue of human membrane cofactor protein (CD46/MCP)
31. Discordant organ xenotransplantatlon in primates
32. Acute vascular rejection
33. Delayed xenograft rejection
34. Pig-to-primate cardiac xenotransplantation and cyclophosphamide therapy
35. The role of antibodies in acute vascular rejection of pig-to-baboon cardiac transplants
36. Humoral responses to pig-to-baboon cardiac transplantation: Implications for the pathogenesis and treatment of acute vascular rejection and for accommodation
37. Mechanisms of injury in porcine livers perfused with blood of patients with fulminant hepatic failure
38. Anti-Galα1-3Gal antibody response to porcine bone marrow in unmodified baboons and baboons conditioned for tolerance induction
39. Porcine and bovine cartilage transplants in cynomolgus monkey
40. The problem of anti-pig antibodies in pig-to-primate xenografting: Current and novel methods of depletion and/or suppression of production of anti-pig antibodies
41. Effect of porcine endothelial tissue factor pathway inhibitor on human coagulation factors
42. Xenogeneic endothelial cells activate human prothrombin
43. Disseminated intravascular coagulation in association with the delayed rejection of pig-to-baboon renal xenografts
44. Porcine kidney and heart transplantation in baboons undergoing a tolerance induction regimen and antibody adsorption
45. Decreased fibrinolytic activity in porcine-to-primate cardiac xenotransplanation
46. Venular thrombosis is the key event in the pathogenesis of antibody-mediated cardiac rejection
47. Human natural killer lymphocytes directly recognize evolutionarily conserved oligosaccharide ligands expressed by xenogeneic tissues
48. Detection of primary direct and indirect human anti-porcine T cell responses using a porcine dendritic cell population
49. Primary porcine endothelial cells express membrane-bound B7-2 (CD86) and a soluble factor that co-stimulate cyclosporin A-resistant and CD28-dependent human T cell proliferation
50. Interferon-γ elicits arteriosclerosis in the absence of leukocytes
51. Three-month survival of hDAF transgenic pig hearts transplanted into primates
52. Splenectomy improves survival of hDAF pig kidneys in primates
53. Transplantation of discordant xenografts: A review of progress
54. Accommodation of vascularized xenografts: Expression of 'protective genes' by donor endothelial cells in a host Th2 cytokine environment
55. Accommodated xenografts survive in the presence of anti-donor antibodies and complement that precipitate rejection of naive xenografts
56. Expression of hemo oxygenase-1 can determine cardiac xenograft survival
57. Inhibition of xenoreactive natural antibody production by retroviral gene therapy
58. Mixed chimerism induced without lethal conditioning prevents T cell- and anti-Gal alpha 1, 3Gal-mediated graft rejection
59. Oocyte Gal alpha 1,3Gal epitopes implicated in sperm adhesion to the zona pellucida glycoprotein ZP3 are not required for fertilization in the mouse
60. The α-1,3-galactosyltransferase knockout mouse
61. Production of goats by somatic cell nuclear transfer
62. Sheep cloned by nuclear transfer from a cultured cell line
63. Viable offspring derived from fetal and adult mammalian cells
64. Cloned transgenic calves produced from nonquiescent fetal fibroblasts
65. Full-term development of mice from enucleated oocytes injected with cumulus cells nuclei
66. Human factor IX transgenic sheep produced by transfer of nuclei from transfected fetal fibroblasts
67. Six cloned calves produced from adult fibroblast cells after long-term culture
68. How close are we to implementing gene targeting in animals other than the mouse?
69. Production of gene-targeted sheep by nuclear transfer from cultured somatic cells